News Center

位置：

Honors Announcement

Group News

Media Reports

First Public Notice of the Environmental Impact Assessment for the Technological Upgrade Project of the Active Pharmaceutical Ingredient Workshop at Hebei Guolong Pharmaceutical Co., Ltd.

Category:

Honors Announcement

发布时间：2024-01-17

【概要描述】

First Public Notice of the Environmental Impact Assessment for the Technological Upgrade Project of the Active Pharmaceutical Ingredient Workshop at Hebei Guolong Pharmaceutical Co., Ltd.

I. Basic Project Information

1. Project Name: Technical Renovation Project for the Active Pharmaceutical Ingredient Workshop of Hebei Guolong Pharmaceutical Co., Ltd.

2. Construction Address: Southeast Corner at the Intersection of Xingye Street and Sanxia Road, Shijiazhuang Economic and Technological Development Zone

3. Project Scope: The project will make use of existing workshops and utility facilities, procure additional equipment, and carry out technological upgrades to the existing API production line. Upon completion, the project will adjust the output and product mix of APIs that are not subject to import or export restrictions, increasing annual production capacity by 20.967 tonnes over the existing level.

4. Project Scale: Adjust the output and product mix of API varieties that are not subject to restrictions or prohibitions, increasing production capacity by 20.967 tonnes per year based on the existing level.

II. Name and Contact Information of the Project Owner

Construction Entity Name: Hebei Guolong Pharmaceutical Co., Ltd.

Contact: Wei Xiaowei

Contact number: 18032935650

III. Name of the Unit Preparing the Environmental Impact Report

Guohuan Technology (Hebei) Co., Ltd.

IV. Online Link to the Public Opinion Form

The public may access the link starting from the date of public notice:

Download the public comments form from https://pan.baidu.com/s/1nSTva4BnSv7Se2qTi6WYlQ?pwd=1234 (Extraction code: 1234) and submit your feedback.

V. Methods and Channels for Public Submission of Comments

The public may contact the project developer by letter, fax, email, telephone, or other means.

Construction Entity Name: Hebei Guolong Pharmaceutical Co., Ltd.